BRIEF-Glycomimetics Enters Into Acquisition Agreement With Crescent Biopharma-March 2024-www.financetom.com

BRIEF-Glycomimetics Enters Into Acquisition Agreement With Crescent Biopharma

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Glycomimetics Enters Into Acquisition Agreement With Crescent Biopharma

Nov 3, 2024 1:36 PM

Oct 29 (Reuters) - GlycoMimetics Inc ( GLYC ):

* GLYCOMIMETICS ENTERS INTO ACQUISITION AGREEMENT WITH

CRESCENT

BIOPHARMA

* GLYCOMIMETICS INC ( GLYC ) - CONCURRENT FINANCING OF $200 MILLION

ANTICIPATED

* GLYCOMIMETICS INC ( GLYC ) - STOCKHOLDERS TO OWN APPROXIMATELY 3.1%

COMBINED COMPANY

* GLYCOMIMETICS INC ( GLYC ) - CRESCENT STOCKHOLDERS TO OWN

APPROXIMATELY

96.9% OF COMBINED COMPANY

Source text:

Further company coverage:

Previous page： Amtech Systems Insider Bought Shares Worth $275,041, According to a Recent SEC Filing Next page： Estee Lauder Companies Insider Bought Shares Worth $2,957,333, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Amtech Systems Insider Bought Shares Worth $275,041, According to a Recent SEC Filing

Feb 10, 2025

04:13 PM EST, 02/10/2025 (MT Newswires) -- Robert M Averick, 10% Owner, Director, on February 07, 2025, executed a purchase for 54,789 shares in Amtech Systems ( ASYS ) for $275,041. Following the Form 4 filing with the SEC, Averick has control over a total of 2,822,289 common shares of the company, with 560,789 shares held directly and 2,261,500 controlled...

Estee Lauder Companies Insider Bought Shares Worth $2,957,333, According to a Recent SEC Filing

Feb 10, 2025

04:12 PM EST, 02/10/2025 (MT Newswires) -- Paul J Fribourg, Director, on February 07, 2025, executed a purchase for 45,500 shares in Estee Lauder Companies ( EL ) for $2,957,333. Following the Form 4 filing with the SEC, Fribourg has control over a total of 524,300 Class A common shares of the company, with 4,000 shares held directly and 520,300...

Match Group Insider Bought Shares Worth $2,049,704, According to a Recent SEC Filing

Feb 10, 2025

04:12 PM EST, 02/10/2025 (MT Newswires) -- Spencer M Rascoff, Director, Chief Executive Officer, on February 06, 2025, executed a purchase for 59,560 shares in Match Group ( MTCH ) for $2,049,704. Following the Form 4 filing with the SEC, Rascoff has control over a total of 59,560 common shares of the company, with 59,560 shares held directly. SEC Filing:...

Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand

Feb 10, 2025

Feb 10 (Reuters) - Vertex Pharmaceuticals ( VRTX ) forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its cystic fibrosis drugs and early contributions from a newly approved non-opioid painkiller. The drugmaker is looking to its acute pain drug, Journavx, to drive growth beyond its established line of cystic fibrosis treatments. Vertex expects...